Showing results (131-140 of 344) with videos related to

Sort By:
Pageof 35
Cancer Science|August 21, 2015
Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myelomaKosei Matsue, Hiromi Iwasaki, Takaaki Chou, et al.
Chemmedchem|January 10, 2014
Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitorsTakayoshi Suzuki, Nobusuke Muto, Masashige Bando, et al.
Cancer Medicine|January 12, 2024
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantationKentaro Hirade, Shigeru Kusumoto, Hiroya Hashimoto, et al.
Pediatric Research|April 30, 2026
Neuroblastoma cell growth and survival promoted by DNMT3B and its inhibition demonstrates anti-tumor effectsKazuya Izumi, Hiromasa Aoki, Kohki Toriuchi, et al.
Blood|February 7, 2004
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietinJianmin Ding, Hirokazu Komatsu, Atsushi Wakita, et al.
Cancer Science|January 24, 2015
TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activitiesMorihiko Sagawa, Takayuki Tabayashi, Yuta Kimura, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2023
The Relationship between Changes in Serum Element Concentrations and Pathological Condition and Disease Status in Japanese Multiple Myeloma Patients: A Pilot Study and Literature ReviewYuko Yamamoto, Masahiro Kondo, Yuji Hotta, et al.
International Journal of Hematology|September 5, 2023
Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11Shinsuke Iida, Kazutaka Sunami, Yuko Mishima, et al.
Japanese Journal of Clinical Oncology|January 21, 2011
Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112Takaaki Chou, Kensei Tobinai, Naokuni Uike, et al.
Plos One|June 27, 2015
Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple MyelomaTakashi Watanabe, Masato Mitsuhashi, Morihiko Sagawa, et al.
Pageof 35